Autoimmune thrombophilic syndromes.
Greaves
M
M
Department of Medicine and Therapeutics, University of Aberdeen, Scotland. m.greaves@abdn.ac.uk
D000026:Abortion, Habitual / Q000276:immunology / Q000628:therapy; D017152:Antibodies, Antiphospholipid / Q000276:immunology; D016736:Antiphospholipid Syndrome / Q000097:blood / Q000175:diagnosis / Q000276:immunology*; D001327:Autoimmune Diseases / Q000097:blood / Q000175:diagnosis / Q000276:immunology*; D002986:Clinical Trials as Topic; D005260:Female; D006023:Glycoproteins / Q000276:immunology; D006493:Heparin / Q000009:adverse effects; D006801:Humans; D016682:Lupus Coagulation Inhibitor / Q000276:immunology; D008180:Lupus Erythematosus, Systemic / Q000097:blood / Q000276:immunology; D008563:Membrane Lipids / Q000276:immunology; D010743:Phospholipids / Q000276:immunology; D011247:Pregnancy; D011697:Purpura, Thrombotic Thrombocytopenic / Q000276:immunology; D013921:Thrombocytopenia / Q000139:chemically induced / Q000175:diagnosis / Q000276:immunology; D019851:Thrombophilia / Q000097:blood / Q000276:immunology*; D053482:beta 2-Glycoprotein I
D017152:Antibodies, Antiphospholipid; D006023:Glycoproteins; D016682:Lupus Coagulation Inhibitor; D008563:Membrane Lipids; D010743:Phospholipids; D053482:beta 2-Glycoprotein I; D006493:Heparin